BETA — Beta Drugs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Beta Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	104	173	192	286	1,470
Net Total Accounts Receivable
Net Total Receivables	382	531	714	923	1,119
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	680	970	1,277	1,779	3,311
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	393	507	581	592	804
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,175	1,579	1,984	2,541	4,362
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	333	490	630	847	1,028
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	489	655	755	970	2,391
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	686	923	1,229	1,571	1,971
Total Liabilities & Shareholders' Equity	1,175	1,579	1,984	2,541	4,362
Total Common Shares Outstanding